about
Integrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancersMutation analysis of genes that control the G1/S cell cycle in melanoma: TP53, CDKN1A, CDKN2A, and CDKN2BHepatolithiasis and intrahepatic cholangiocarcinoma: A review.Genetic and Chromosomal Aberrations and Their Clinical Significance in Renal NeoplasmsThe Impact of Genomic Profiling for Novel Cancer Therapy--Recent Progress in Non-Small Cell Lung CancerStrain-dependent lung tumor formation in mice transplacentally exposed to 3-methylcholanthrene and post-natally exposed to butylated hydroxytolueneOcular expression and distribution of products of the POAG-associated chromosome 9p21 gene regionRole of mammalian Ecdysoneless in cell cycle regulationWhole blood DNA aberrant methylation in pancreatic adenocarcinoma shows association with the course of the disease: a pilot studyNovel rank-based statistical methods reveal microRNAs with differential expression in multiple cancer typesEvaluation of the use of therapeutic peptides for cancer treatmentTAPO: A combined method for the identification of tandem repeats in protein structures.Cancer risk and the ATM gene: a continuing debate.The 9p21 susceptibility locus for coronary artery disease and the severity of coronary atherosclerosis.A Phase I Study of the Cyclin-Dependent Kinase 4/6 Inhibitor Ribociclib (LEE011) in Patients with Advanced Solid Tumors and LymphomasHypermethylation of CDKN2A exon 2 in tumor, tumor-adjacent and tumor-distant tissues from breast cancer patients.Cancer epigenetics: a brief review.DNA methylation: potential biomarker in Hepatocellular Carcinoma.Molecular Drivers of Pancreatic Cancer Pathogenesis: Looking Inward to Move Forward.DNA copy number losses in human neoplasms.Genomics of squamous cell lung cancerPancreatic cancer genomics: insights and opportunities for clinical translationTowards a HPC-oriented parallel implementation of a learning algorithm for bioinformatics applications.Squamous carcinoma of the head and neck: molecular mechanisms and potential biomarkers.Hyperleukocytic leukemias and leukostasis: a review of pathophysiology, clinical presentation and management.Clinical and scientific impact of human papillomavirus on head and neck cancer.Cigarette smoking and p16INK4α gene promoter hypermethylation in non-small cell lung carcinoma patients: a meta-analysis.DNA methylation in endometrial cancerThe meaning of p16(ink4a) expression in tumors: functional significance, clinical associations and future developmentsPotential molecular prognostic markers in head and neck squamous cell carcinomas.Diagnostic and prognostic tumor markers in the gastrointestinal tract.Methylation and colorectal cancer.LRpath analysis reveals common pathways dysregulated via DNA methylation across cancer typesA p-Median approach for predicting drug response in tumour cells.Reprogrammable CRISPR/Cas9-based system for inducing site-specific DNA methylation.The specificity and patterns of staining in human cells and tissues of p16INK4a antibodies demonstrate variant antigen binding.Association between P(16INK4a) promoter methylation and non-small cell lung cancer: a meta-analysis.Telomere dysfunction alters the chemotherapeutic profile of transformed cellsDifferentiation of human malignant melanoma cells that escape apoptosis after treatment with 9-nitrocamptothecin in vitro.Genome-wide molecular characterization of central nervous system primitive neuroectodermal tumor and pineoblastoma.
P2860
Q24649562-21C41922-F565-4BE0-BE71-CC99FE453A11Q24801244-F9558B0E-EF3D-4B31-9FF0-64055458150FQ26771199-5DFBE3D9-95F0-4CFB-A99C-E1E917A4A713Q26785930-2C78563A-1B99-4263-AB65-AB3769D3C02CQ28067196-547786BF-A075-4289-B4A3-D763426492FBQ28375629-41253797-7154-44AF-8D32-0EF6DE81C6A4Q28572262-5325F75B-4401-43B8-BB88-D9BD984E2D8AQ28588460-975E249F-6E99-4053-B7FF-DBBD4BD0B359Q28729757-25FFB196-9AFE-4ED3-A182-E9FA0431F086Q28750147-3CF90167-956C-4852-944C-D0CA677F6030Q29048586-BC0D55A7-9CE2-488D-BE14-3A8901EF603EQ30378558-56302053-D6BD-43D6-938B-8C3765952B31Q30871076-6A9443B7-D896-4398-AE72-CD39FC414F5EQ33403360-AFF88532-9670-405E-95D4-835CC404E8ACQ33434752-85F83236-CF0D-4DCE-B24B-E3EAB131A142Q33556583-6942D926-66B7-4A74-88E9-229F940DAC11Q33614190-67F63951-8611-401D-9EA2-FEEF0D97D2FFQ33617129-013E2D53-A54E-4418-AB8D-5BF69351854CQ33624574-EB89CA55-3542-4765-AD8E-1FF2FFCDADE6Q33733232-8E66D179-DC26-4698-B50F-C3EF41C8A944Q33777454-CB4946E6-FF86-4446-B38E-9F3AF0078685Q33781071-D7DE9605-0D81-405A-8E22-67A96A498A51Q33891897-297DA25A-D6C6-4C7C-88E1-38AA0BF548E3Q34005879-7FA44BF5-B387-498A-90AD-BF06F2464C3DQ34024225-3A3254A1-0A2E-4CA9-A9F6-28968054A59FQ34031281-00219748-0EF3-42C9-8BF3-8DC7A2820666Q34103461-9C74473C-6F04-48A6-B101-B3B87850AB3CQ34195371-92C7724E-1F69-425B-B07E-47C823B1E127Q34202289-0608B9CD-A093-42BF-A1CC-F3719322EFB1Q34219833-744ECDB4-185A-4B91-B852-0AC5276716B6Q34277292-1E796000-B102-4B21-84C4-CC761742F7C6Q34378429-1ED64D24-3088-422F-A072-7B13DCB96C96Q34433060-5AEAC66F-A05C-4571-99A6-BF6E7D334FD3Q34463528-A6022258-2A92-43F7-A5ED-9BC21153ED56Q34526213-9B5F8019-0EC4-4530-AB1A-F6B601F694CFQ34544920-33E628B9-FB15-402B-B3C9-0AE3119EC0C6Q34663640-710EA5D9-AAC7-4CEF-BE0F-EFFC1D7024EBQ34733007-67AB0CE1-748E-4CEE-8C52-DA9BDA5CD9D6Q34786059-D54CAFAC-9BD5-4702-9FF5-6B52DEA327B0Q35133413-3E0CEECE-84CD-494D-96AC-02AFD7D3AE05
P2860
description
1998 nî lūn-bûn
@nan
1998 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի մարտին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Role of the p16 tumor suppressor gene in cancer
@ast
Role of the p16 tumor suppressor gene in cancer
@en
Role of the p16 tumor suppressor gene in cancer
@nl
type
label
Role of the p16 tumor suppressor gene in cancer
@ast
Role of the p16 tumor suppressor gene in cancer
@en
Role of the p16 tumor suppressor gene in cancer
@nl
prefLabel
Role of the p16 tumor suppressor gene in cancer
@ast
Role of the p16 tumor suppressor gene in cancer
@en
Role of the p16 tumor suppressor gene in cancer
@nl
P3181
P1476
Role of the p16 tumor suppressor gene in cancer
@en
P2093
D Sidransky
W H Liggett
P304
P3181
P356
10.1200/JCO.1998.16.3.1197
P407
P577
1998-03-01T00:00:00Z